Comparison between Quicktouch Technologies IPO and Remus Pharmaceuticals IPO.
Quicktouch Technologies IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Remus Pharmaceuticals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Quicktouch Technologies IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Khambatta Securities Ltd. Share India Capital Services Pvt.Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Share India Securities Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Quicktouch Technologies IPO is up to ₹8.86 Cr whereas the issue size of the Remus Pharmaceuticals IPO is up to ₹45.29 Cr. The final issue price of Quicktouch Technologies IPO is ₹61.00 per share and of Remus Pharmaceuticals IPO is ₹1,229.00 per share.
| Quicktouch Technologies IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹1,150.00 per share | |
| Issue Price (Upper) | ₹1,229.00 per share | |
| Issue Price (Final) | ₹61.00 per share | ₹1,229.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 100 shares |
| Fresh Issue Size | 14,52,000 shares | 3,68,500 shares |
| Fresh Issue Size (Amount) | up to ₹8.86 Cr | up to ₹45.29 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 14,52,000 shares | 3,68,500 shares |
| Issue Size Total (Amount) | up to ₹8.86 Cr | up to ₹45.29 Cr |
Quicktouch Technologies IPO opens on Apr 18, 2023, while Remus Pharmaceuticals IPO opens on May 17, 2023. The closing date of Quicktouch Technologies IPO and Remus Pharmaceuticals IPO is Apr 21, 2023, and May 19, 2023, respectively.
| Quicktouch Technologies IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | May 16, 2023 | |
| Issue Open | Apr 18, 2023 | May 17, 2023 |
| Issue Close | Apr 21, 2023 | May 19, 2023 |
| Basis Of Allotment (Tentative) | Apr 26, 2023 | May 24, 2023 |
| Initiation of Refunds (Tentative) | Apr 27, 2023 | May 25, 2023 |
| Credit of Share (Tentative) | Apr 28, 2023 | May 26, 2023 |
| Listing date (Tentative) | May 02, 2023 | May 29, 2023 |
| Anchor Lockin End date 1 | Jun 23, 2023 | |
| Anchor Lockin End date 2 | Aug 22, 2023 |
Quicktouch Technologies IPO P/E ratio is , as compared to Remus Pharmaceuticals IPO P/E ratio of 21.09.
| Quicktouch Technologies IPO | Remus Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.41 | 92.82 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 65.72 | 68.37 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 21.09 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹35.26 Cr. | ₹181.03 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 71.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 69.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹33.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 52.64 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Quicktouch Technologies IPO Retail Individual Investors (RII) are offered 7,26,000 shares while in Remus Pharmaceuticals IPO retail investors are offered 7,26,000 shares. Qualified Institutional Buyers (QIB) are offered in Quicktouch Technologies IPO and 73,700 shares in Remus Pharmaceuticals IPO.
| Quicktouch Technologies IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,10,500 shares | |
| Market Maker Reservation | 78,000 shares | 19,500 shares |
| QIB | 73,700 shares | |
| NII | 7,26,000 shares | 55,300 shares |
| RII | 7,26,000 shares | 1,29,000 shares |
| Employee | ||
| Others | ||
| Total | 14,52,000 shares | 3,68,500 shares |
Quicktouch Technologies IPO subscribed 113.02x in total, whereas Remus Pharmaceuticals IPO subscribed 57.21x.
| Quicktouch Technologies IPO | Remus Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 10.75x | |
| NII (times) | 169.01x | 229.31x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 52.21x | 49.81x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 113.02x | 57.21x |
